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After an ischemic stroke, neural precursor cells (NPCs) proliferate within major germinal
niches of the brain. Endogenous NPCs subsequently migrate toward the ischemic lesion
where they promote tissue remodeling and neural repair. Unfortunately, this restorative
process is generally insufﬁcient and thus unable to support a full recovery of lost neurolog-
ical functions. Supported by solid experimental and preclinical data, the transplantation of
exogenous NPCs has emerged as a potential tool for stroke treatment.Transplanted NPCs
are thought to act mainly via trophic and immunemodulatory effects, thereby complement-
ing the restorative responses initially executed by the endogenous NPC population. Recent
studies have attempted to elucidate how the therapeutic properties of transplanted NPCs
vary depending on the route of transplantation. Systemic NPC delivery leads to potent
immune modulatory actions, which prevent secondary neuronal degeneration, reduces
glial scar formation, diminishes oxidative stress and stabilizes blood–brain barrier integrity.
On the contrary, local stem cell delivery allows for the accumulation of large numbers of
transplanted NPCs in the brain, thus achieving high levels of locally available tissue trophic
factors, which may better induce a strong endogenous NPC proliferative response. Herein
we describe the diverse capabilities of exogenous (systemically vs. locally transplanted)
NPCs in enhancing the endogenous neurogenic response after stroke, and how the route
of transplantation may affect migration, survival, bystander effects and integration of the
cellular graft. It is the authors’ claim that understanding these aspects will be of pivotal
importance in discerning how transplanted NPCs exert their therapeutic effects in stroke.
Keywords: cell therapy, neurogenesis, stroke, blood–brain barrier, brain plasticity, neuroprotection
INTRODUCTION
Ischemic stroke represents the most common cause of serious
morbidity and the second most common cause of mortality in
industrialized countries (Donnan et al., 2008). While a certain
degree of spontaneous recovery of lost functions takes place in
some stroke patients, the majority never regain full functional
independence and ultimately suffer from a reduced quality of life
(Lloyd-Jones et al., 2009). Clearly, this health burden represents
a major unmet clinical need that may in part be fulﬁlled via a
detailed understanding of the mechanisms driving neurological
recovery after stroke.
In animal models, the mobilization and recruitment of NPCs
from the major stem cell niches within the central nervous system
Abbreviations: BDNF, brain-derived neurotrophic factor; BMP, bone morpho-
genetic protein; CCL,CC chemokine ligands; CSPGs, chondroitin sulfate proteogly-
cans; CNTF, ciliary neurotrophic factor; GDNF, glial cell line-derived neurotrophic
factor; HO-1, heme oxygenase 1; IFN-γ, interferon-γ; IGF1, insulin-like growth
factor-1; IL, interleukin; LIF, leukemia inhibitory factor; MMPs, matrix metallo-
proteinases; NGF, nerve growth factor; NO, nitric oxide; NPCs, neural precursor
cells; NT-3, neurotrophin-3; PGE, prostaglandin E; SDF-1α, stromal cell-derived
factor-1α; SHH, sonic hedgehog homolog; SVZ, subventricular zone; TIMPs, tis-
sue inhibitors of metalloproteinases; TN-C, tenascin-C; TNF-α, tumor necrosis
factor-α; TSP, thrombospondin; VEGF, vascular endothelial growth factor.
[CNS; i.e., the sub-ventricular zone (SVZ) of the lateral ventri-
cles and the sub-granular zone of the dentate gyrus (DG)] are
essential compensatory responses after an ischemic insult (Arvids-
son et al., 2002). However, while it is known that endogenous
NPCs do positively enhance the brain’s own restorative poten-
tial via trophic inﬂuences on the ischemic microenvironment,
the overall neurogenic response after stroke is insufﬁcient for a
number of reasons, which include the limited survival of NPCs,
their transient mobilization from the neurogenic niches and their
incomplete integration within damaged brain circuitries (Thored
et al., 2007).
The observation that NPCs can be harvested from the adult
brain and used therapeutically in animal models of stroke argues
in favor of the potential utility of cell-based therapies in ischemic
stroke. We have shown that the injection of somatic mouse
NPCs ameliorates the clinicopathological features of stroke in
relevant murine models by reducing secondary neurodegener-
ation, decreasing glial scar formation, promoting endogenous
neurogenesis and stabilizing blood–brain barrier (BBB) integrity
(Bacigaluppi et al., 2009; Doeppner et al., 2012). Grafted NPCs
adapt to the ischemic microenvironment and facilitate homeosta-
sis via the secretion of numerous tissue trophic factors that have
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beneﬁcial effects on endogenous brain cells, as well as modulatory
actions on both innate and adaptive immune responses (Pluchino
and Cossetti, 2013). This concept has now come to be known
as functional stem cell multipotency, and it is one of the core
tenants behind the use of NPC grafts in attempt to boost the
recovery potential of the ischemic brain (Martino and Pluchino,
2006).
However, there remains an enormous need to understand how
the complex interactions of stem cell grafts with the ischemic
brain may be affected by the route and timing of cell delivery. In
particular, we still have to deﬁne how NPCs should best be admin-
istered in order to enhance endogenous restorative responses that
depend on (i) the homing, survival and integration of trans-
planted NPCs, (ii) the proliferation of the host’s endogenous
NPCs, (iii) the modiﬁcation of the cerebral microenvironment,
and (iv) the remodeling of ischemic tissue via actions that include
the modiﬁcation of glial responses and the promotion of neuronal
plasticity.
Herein, we summarize current knowledge with regard to how
transplanted NPCs interact with host tissues, aiming to iden-
tify how exogenously delivered NPCs may eventually be used
to promote neurological recovery in mouse models of ischemic
stroke.
REGULATION OF ENDOGENOUS NEUROGENESIS AFTER
STROKE
The SVZ is situated within the lateral walls of the lateral ventricles
and is composed of four main cell types: ciliated ependymal cells
(type E), slowly proliferating stem cells (type B), transient ampli-
fying progenitors (type C) and proliferating neuroblasts (type A;
Mirzadeh et al., 2008). After an ischemic stroke that involves the
striatum, the number of type A and C cells in the SVZ is per-
sistently increased, while type B and E cells undergo a period
of transient proliferation (Zhang et al., 2004, 2007). Increases in
mitotic activity within the SVZ appear to peak between 7 and
10 days, subsequently decrease during weeks 3–5 post-stroke, and
thereafter continues at lower levels over the course of the following
year (Arvidsson et al., 2002; Parent et al., 2002; Thored et al., 2006).
This suggests that the SVZ may serve as a constant reservoir of new
neurons after stroke even in the chronic phases of recovery, and
thereby offers an extended window of opportunity for therapeutic
intervention.
Signals that stimulate the stroke-induced neurogenic response
have yet to be fully elucidated, but likely involve the interplay of
morphogens, growth factors, and inﬂammatory mediators. Sev-
eral groups have found that the notch pathway stimulates SVZ
cell proliferation and neurogenesis after stroke (Androutsellis-
Theotokis et al., 2006;Wang et al., 2009). Other signaling pathways
that appear to be important for stroke-induced neurogenesis
include retinoic acid (RA), sonic hedgehog (SHH), and bone mor-
phogenic protein (BMP; Chou et al., 2006; Plane et al., 2008; Sims
et al., 2009; Kernie and Parent, 2010). Soluble growth factors,
such as basic ﬁbroblast growth factor (bFGF), BDNF, epider-
mal growth factor (EGF), glial cell-derived neurotrophic factor
(GDNF), erythropoietin (EPO), CNTF, transforming growth fac-
tor (TGF)-α, VEGF, and granulocyte-colony stimulating factor
(G-CSF), have also been inextricably linked to stroke-induced
neurogenesis (Kokaia et al., 1995; Planas et al., 1998; Kitagawa
et al., 1999; Sun et al., 2003; Schneider et al., 2005; Tureyen
et al., 2005; Leker et al., 2009; Kang et al., 2012). Inﬂammatory
mediators have been shown to have variable effects on NPC pro-
liferation, migration, survival, and incorporation within injured
CNS circuitries (Peruzzotti-Jametti et al., 2014). Some studies
have indeed reported that activated microglial cells can reduce
NPC viability through the secretion of soluble molecules such
as IFN-γ, IL-1β, IL-6, and tumour necrosis factor (TNF)-α or
by direct cell-to-cell contact (Ben-Hur et al., 2003; Cacci et al.,
2008). Other studies suggest instead that microglial cells can
increase neurogenesis via TNF-α/ TNF-R2 interaction or insulin-
like growth factor (IGF)-1 secretion (Heldmann et al., 2005;
Thored et al., 2009). These differential effects of inﬂammation,
which appear to either support or impair the adult neurogenic
response, most likely depend on the phenotype of the inﬂam-
matory cells (and their cytokine production proﬁle; Ekdahl et al.,
2009).
Since NPCs can secrete many of the factors that regulate
neurogenesis (Drago et al., 2013), and are also able to ben-
eﬁcially modulate inﬂammatory responses after CNS damage
(Bacigaluppi et al., 2009; Cusimano et al., 2012), the possi-
bility of exploiting NPC transplantation in an effort to aug-
ment endogenous neurogenesis and the brain’s spontaneous
reparative processes (e.g., plasticity) after stroke is readily
apparent. In this review, cellular and molecular interac-
tions of NPCs with the brain environment have been illus-
trated in Figure 1. Effects of exogenously delivered NPCs
in experimental models of stroke have been summarized in
Table 1.
EFFECTS OF TRANSPLANTED NPCs ON ENDOGENOUS
NEUROGENESIS
In view of their intrinsic actions, the possibility of exploitingNPCs
in an effort to augment endogenous neurogenesis has been the
focus of intensive research efforts. Among the different routes of
NPC delivery, there are several studies suggesting that the local
(i.e., intracerebral or intracerebroventricular) administration of
NPCs has the most relevant effects on endogenous neurogenesis.
The local route of cell delivery indeed allows for a large num-
ber of cells to be administered, which facilitates the secretion of
high concentrations of growth factors that ultimately promote the
endogenous neurogenic response (Hao et al., 2014). In line with
the need for an efﬁcient accumulation of NPCswithin the ischemic
parenchyma, the intravenous administration of NPCsmay be infe-
rior with regard to the stimulation of neurogenesis. As such, when
mouse embryonic stem (ES)-derivedNPCswere transplanted 24 h
after photothrombotic stroke in adult immunosuppressed rats, no
effect on post-stroke neurogenesis of the SVZ was shown, and
a decrease in newly generated neurons in the DG was observed
(Minnerup et al., 2011).
The early transplantation of human NPCs has instead been
proven highly effective in stimulating endogenous neurogene-
sis in rats when cells were delivered directly into the ischemic
brain parenchyma. Human fetal NPCs, injected in the cortical
peri-infarct tissue 24 h after permanent middle cerebral artery
occlusion (MCAO) promoted cell proliferation in the SVZ (up
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FIGURE 1 | Neural precursor cell (NPC) transplantation boosts the
endogenous neurogenic response after stroke. NPC proliferation within
the SVZ is augmented after stroke leading to the generation of newly
formed neuroblasts that migrate along vessels toward gradients of
chemokines that are produced locally by glial and inﬂammatory cells (e.g.,
CCL2, SDF1-α, and EPO). The bystander effects of transplanted NPCs
depend on the release of several factors (e.g., BMP, SHH, NGF, BDNF,
CNTF, GDNF, NT-3, and VEGF) that can directly increase cell proliferation
within the SVZ, potentiate neuroblasts migration, and augment
peri-ischemic angiogenesis. Transplanted NPCs can also positively affect the
differentiation of endogenous neuroblasts and plasticity within the ischemic
tissue (via the secretion of NGF, BDNF, CNTF, GDNF, NT-3, MMPs, TIMPs,
CSPGs, TN-C, VEGF, TSP1-2, Slit), or directly differentiate into post-mitotic
neurons, astrocytes, or oligodendrocytes. Most importantly, transplanted
NPCs secrete a plethora of soluble molecules that modulate the activation
of host microglia/macrophages (e.g., BMP, LIF, NO, PGE, HO-1, VEGF, TN-C),
thus modifying the release of inﬂammatory mediators that inhibit (e.g.,
TNF-α, IFN-γ, IL1β, IL6) or increase (e.g., TNF-α, IGF1) endogenous
neurogenesis. Green dots represent mediators secreted by inﬂammatory
cells.
to 15 days post-stroke) and increased angiogenesis in peri-infarct
regions (Zhang et al., 2011). Intraparenchymal cell delivery has
also yielded possible evidence of therapeutic potential when
administered in the subacute and chronic phases of the stroke.
A study with human fetal NPCs transplanted 2 days after MCAO
showed that the intraparenchymal injection of NPCs was able to
promote endogenous neurogenesis in multiple ways (Mine et al.,
2013). Transplanted cells were able to induce a prolonged increase
in Ki67+ proliferating cells within the SVZ, which was associ-
ated with an increase in the number of endogenous neuroblasts
Frontiers in Cellular Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 291 | 3
Hermann et al. Neural precursors in ischemic brain
Table 1 | Effects of exogenously delivered NPCs in experimental stroke models.
Study Experimental paradigm Observations
Andres et al. (2011a) Intraarterial delivery of adult NPCs obtained fromCCR2+/+
and CCR2-/- mice 24 h after transient (30 min) common
carotid artery occlusion combined with 8% hypoxia in
CCL2+/+ and CCL2-/- mice
Decreased homing of CCR2-/- NPCs compared with CCR2+/+
NPCs in CCL2+/+mice. Decreased homing of CCR2+/+ NPCs in
CCL2-/- compared with CCL2+/+mice. Mice receiving CCR2+/+
NPCs showed signiﬁcantly better neurological recovery than ani-
mals receiving CCR2-/- NPCs.
Andres et al. (2011b) Intracerebral delivery of fetal human NPCs 7 days after
permanent distal MCAO combined with transient (30 min)
bilateral common carotid artery occlusion in rats
Increased dendritic plasticity in ipsi- and contralesional cortex after
NPC delivery that coincided with functional neurological recovery.
Increased corticocortical, corticostriatal, corticothalamic and cor-
ticospinal axonal sprouting from the contralesional hemisphere
associated with transcallosal and corticospinal axonal sprouting.
Reduced brain amyloid precursor protein accumulation.
Bacigaluppi et al. (2009) Intravenous delivery of adult mouse NPCs 3 days after
transient (45 min) proximal (intraluminal) MCAO in mice
Improved neurological recovery after NPC delivery. Small per-
centage of transplanted NPCs (< 1%) accumulated in the brain,
integrating mainly in the infarct boundary zone, where most of the
NPCs remained undifferentiated. Reduced secondary striatal and
corpus callosum atrophy associated with downregulation of mark-
ers of inﬂammation, glial scar formation and neuronal apoptotic
death.
Darsalia et al. (2011) Intracerebral delivery of fetal human NPCs 48 h or 6 weeks
after transient (30 min) proximal MCAO in rats
Better NPC survival after early than late NPC transplantation. Mag-
nitude of NPC proliferation, migration, and neuronal differentiation
was not inﬂuenced by transplantation time. Greater numbers of
grafted NPCs did not result in greater numbers of surviving NPCs
or increased neuronal differentiation.
Doeppner et al. (2012) Intravenous or intracerebral delivery of adult mouse NPCs
6 h after transient (30 min) proximal (intraluminal) MCAO
in mice
Intravenous and intracerebral NPC delivery similarly induced neu-
rological recovery, but only intravenous NPC delivery yielded
sustained neuroprotection that persisted in the post-acute stroke
phase. Intracerebral NPF delivery associated with higher brain
concentrations of BDNF, FGF, and VEGF. Intravenous, but not
intracerebral NPC delivery stabilized blood–brain barrier, reduced
activation of MMP9 and decreased formation of reactive oxygen
species.
Hassani et al. (2012) Intracerebral delivery of human conditionally immortalized
neural stem cells CTX0E03 4weeks after transient (60min)
proximal (intraluminal) MCAO in rats
Increased endogenous NPC proliferation in striatum of NPC
treated rats. Signiﬁcant proportion of proliferative cells expressed
immature neuronal marker doublecortin. Increased proliferation of
CD11b + microglial cells in NPC treated rats.
Jin et al. (2005) Intravenous, intracerebral or intracerebroventricular deliv-
ery of embryonic mouse NPCs 24 h after permanent distal
MCAO in rats
Brain entry of NPCs with accumulation in ischemic striatum and
cortex observed using all three delivery strategies, intrastriatal
transplants resulting in highest and intravenous transplants in low-
est cell densities. Majority of cells expressing undifferentiated
neuroepithelial (nestin) or neuronal (doublecortin) markers.
Mine et al. (2013) Intracerebral delivery of fetal human NPCs 48 h after
transient (60 min) proximal MCAO inT cell deﬁcient rats
Subpopulation of NPCs exhibited differentiated neuronal
phenotype at 6 and 14 weeks. Numbers of proliferating
endogenous NPCs were elevated, and numbers of activated
microglia/macrophages were reduced in ischemic striatum of
NPC treated rats. Some grafted NPCs projected axons from
striatum to globus pallidus. NPC treated rats showed improved
neurological recovery.
Minnerup et al. (2011) Intravenous delivery of embryonic mouse NPCs 24 h
after photothrombotic stroke in immunosuppressed
(cyclosporine A) rats
Improved neurological recovery associated with increased den-
dritic growth and branching, reduced endogenous neurogenesis
and increased microglial activation in NPC treated rats.
Tang et al. (2014) Intracerebral delivery of embryonic mouse NPCs 24 h
after transient (120 min) proximal MCAO in young-adult
(3 month-old) and aged (24 month-old) rats
Aged rats developed larger infarcts with worse neurological
deﬁcits than young-adult rats. Brain infarction and neurologic
deﬁcits were attenuated by NPC delivery in aged and young-adult
rats. Number of surviving NPCs was similar in both age groups.
Angiogenesis and neurogenesis were enhanced by NPCs in aged
and young-adult rats.
Zhang et al. (2011) Intracerebral delivery of fetal human NPCs 24 h after
permanent distal MCAO in rats
Increased proliferation of endogenous NPCs in ipsilesional
(ischemic) subventricular zone of rats receiving NPC grafts.
Enhanced angiogenesis in peri-infarct cortex.
List of major studies using ischemic stroke models, in alphabetic order.
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survival, migration and maturation in the striatum. This pro-
longed endogenous neurogenic response, which persisted up
to 14 weeks, was accompanied by the long-term suppression
of microglia/macrophage driven inﬂammatory responses (Mine
et al., 2013). Similarly, when human conditionally immortalized
NPCs (cell line CTX0E03) were transplanted in immunosup-
pressed rats 4 weeks after MCAO, the number of proliferat-
ing doublecortin (DCX)+ neuroblasts considerably increased in
the ischemic striatum (Hassani et al., 2012). Interestingly, the
authors attributed this ﬁnding to an increase (rather than a
decrease) of proliferating microglia in the striatum (Hassani et al.,
2012).
Despite these data, which highlight the promising effects of
intraparenchymal NPC delivery, comparative studies of differ-
ent routes and times of transplantation (without the use of
confounding immunosuppressive regimens) must be performed
in order to determine the optimal spatiotemporal settings that
would allow for the ideal stimulation of endogenous neurogen-
esis in stroke. Additionally, given that the neurogenic potential
of adult NPCs declines with age (Conover and Shook, 2011), the
effect of NPC transplantation in aged brains also warrants inves-
tigation. Interestingly, a recent study has shown that the local
NPC transplantation (24 h post-ischemia) is capable of simi-
lar increases in neurogenesis and angiogenesis in the ischemic
striatum of both young and aged mice (Tang et al., 2014). The
aforesaid, coupled with recent data showing increased neuroge-
nesis in the SVZ of both young and aged animals following the
local administration of human ES-derived NPCs, suggests that
the ischemic environment may effectively be modiﬁed in order to
restore deﬁcient neurogenic responses in the aged brain as well
(Jin et al., 2011).
HOMING AND SURVIVAL OF TRANSPLANTED NPCs
In a comparative study evaluating intrastriatal, intracerebroven-
tricular and intravenous NPC delivery (24 h after MCAO), the
intrastriatal transplant of NPCs yielded the highest numbers of
grafted cells within the ischemic brain (Jin et al., 2005). Intracere-
broventricular transplantation into the lateral ventricle led to the
survival of less cells, yet more cells were found when compared
to intravenous NPC delivery (Jin et al., 2005). The reasons behind
these observations are manifold in nature and may be linked to
both the differential homing of grafted cells and their distinct
survival proﬁles within the ischemic brain.
The mechanisms that regulate the homing of transplanted cells
to the ischemic lesion are extremely similar to those that regulate
the migration from within the endogenous NPC compartment
(Jin et al., 2003; Zhang et al., 2009). Upon ischemia, EPO acti-
vates endothelial cells, which promote endogenous neuroblasts
migration by secreting MMPs that degrade extracellular matrix
(ECM) components (Wang et al., 2006). Migration of neurob-
lasts along the vessels is then modulated by the interaction of
chemokine receptors on NPCs [e.g., C-X-C motif chemokine
receptor (CXCR)-4 and C-C motif chemokine receptor (CCR2)]
withmolecules secreted by activated neuronal and glial cells within
the ischemic lesion [e.g., stromal-derived factor (SDF)-1α andC-C
chemokine ligand (CCL)-2, respectively; Robin et al., 2006; Yan
et al., 2007].
When exogenous NPCs are administered intravenously, the
crossing of the BBB involves a further degree of complexity. The
CCL2/CCR2 interaction has been demonstrated to be critical for
transendothelial recruitment of intraarterially delivered NPCs in
response to ischemic injury (Andres et al., 2011a). Stem cells in
circulation directly enter the injured brain through endothelial
rolling and adhering on cadherins (VCAM-1) and integrins that
become selectively up-regulated within the zone of ischemic dam-
age (Mueller et al., 2006). This phenomenon, coupled with the
disturbance of BBB integrity that occurs as a consequence of
ischemia, is responsible for the pathotropism of transplantedNPCs
for ischemic tissue that occurs after systemic delivery. Interestingly,
intravenous transplantation of NPCs has the unique advantage
of stabilizing the BBB, via mechanisms that involve a reduc-
tion of MMP9 expression and reactive oxygen species (ROS), as
we recently showed after the transplantation of adult NPCs at
6 h after transient MCAO (Doeppner et al., 2012). Despite the
fact that systemic NPC transplantation yields fewer cells in the
ischemic brain parenchyma, current evidence suggests that intra-
venous injection is clearly able to promote neuronal/glial survival
at delayed time-points (Bacigaluppi et al., 2009; Doeppner et al.,
2012). As such, while intracerebrally transplanted adult mouse
NPCs transiently improved motor coordination during the ﬁrst
1–2 weeks after MCAO in mice, intravenous NPC transplan-
tation resulted in persistent motor coordination improvements
that persisted over at least 8 weeks post-stroke (Doeppner et al.,
2012).
We have previously shown that upon the intravenous trans-
plantation of adult mouse NPCs in the subacute stroke phase
(72 h post-ischemia) only a small minority of transplanted cells
(approximately 0.3% based on systematic counts) accumulate in
the brain (Bacigaluppi et al., 2009). Notably, within the ﬁrst 72 h
post transplantation, intravenously injected NPCs were found
both in the ischemic and contralesional non-ischemic hemisphere
(Bacigaluppi et al., 2009). In the subsequent 7 days the NPCs in
the contralesional hemisphere disappeared, whereas those in the
ischemic hemisphere steadily increased in number in a narrow
rim around the lesion border. Given that a signiﬁcant proportion
(25%) of transplantedNPCs in themouse brain expressed the pro-
liferation marker Ki67 at 3 days post-transplantation, this selective
accumulation may be explained in part by the local proliferation
of transplanted cells.
Beyond the proliferation of grafted NPCs, their emergence
from peripheral organs (where they may have previously homed),
such as the lungs, liver and spleen (Lappalainen et al., 2008),
may also contribute to the delayed accumulation of systemically
injected cells around the stroke lesion. While the localization of
cells of a neural lineage within peripheral organs may carry health
risks related to malignant transformation, the idea that NPCs
have the capacity to exert their therapeutic efﬁcacy via periph-
eral actions is intriguing. When fetal human NPCs were delivered
intravenously in rats submitted to collagenase-induced intracere-
bral haemorrhage (ICH), these cells were identiﬁed primarily in
secondary lymphoid organs where they induced a reduction in
the levels of inﬂammatory mediators and activated macrophage
numbers (Lee et al., 2008). This effect was found to be therapeu-
tically relevant as splenectomy, performed before ICH, abolished
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the effects of NPC transplantation on both brain oedema and
inﬂammatory inﬁltrates (Lee et al., 2008). This ﬁnding, com-
bined with observations that transplanted NPCs can hamper
the activation of myeloid dendritic cells (DCs) and restrain the
expansion of antigen-speciﬁc T cells in inﬂammatory CNS con-
ditions (Pluchino et al., 2005, 2009), supports the putative ability
of systemically delivered NPCs in modulating important aspects
of the stroke-induced activation of innate and adaptive immune
responses.
It is becoming clear that the therapeutic effect of intravenous
cell delivery is independent of the amount of NPCs that is
achieved within the brain, while local intracerebral NPC trans-
plantation outcomes strictly depend on the amount of NPCs that
reside within the lesion site. Consequently, intracerebral trans-
plantation of NPCs is successful only if grafted NPCs within the
ischemic brain survive in adequate quantity. The major deter-
minant of the survival of locally transplanted cells within the
ischemic brain is the timing of delivery. In a recent study it
has been shown that while NPC proliferation, migration, and
neuronal differentiation did not differ when cells were intras-
triatally transplanted in the subacute (48 h) or chronic phase
(6 weeks) after stroke, NPC survival was strikingly reduced fol-
lowing delayed cell delivery (Darsalia et al., 2011). The reasons
underlying these ﬁndings are largely unknown. It is known that
the majority (approximately 80%) of adult-born neurons aris-
ing from the endogenous neurogenic niche after stroke die before
integrating in the ischemic tissue (Arvidsson et al., 2002), and
that the inﬂammatory milieu plays a pivotal role in this phe-
nomenon. As such, the treatment with anti-inﬂammatory agents
(e.g., indomethacin or minocycline) that suppress microglial
activation result in the preservation of these newly formed
neurons (Hoehn et al., 2005; Liu et al., 2007). Similarly, the sur-
vival of intrastriatal grafts may be strictly dependent on the
local inﬂammatory milieu and, as such, intraparenchymal trans-
plantation should take place before microglial cells are fully
activated.
FUNCTIONAL INTEGRATION OF TRANSPLANTED NPCs
The route of NPC administration has little effect on the phenotype
of cells that accumulate inside the ischemic brain, as transplanted
NPCs via local or systemic routes retain a proﬁle of characteristics
that is similar to those observed in vitro prior to transplanta-
tion (Jin et al., 2005). This may either be interpreted as evidence
that NPCs are able to retain their character, despite the manip-
ulations brought about by transplantation, or that the ischemic
microenvironment arrests the capacity of the transplanted NPCs
to differentiate into mature neurons or glia. It has indeed been
shown that when neuroinﬂammation predominates, transplanted
cells retain an undifferentiated phenotype as a result of the release
of soluble mediators (e.g., noggin) by blood-borne inﬂamma-
tory cells, activated endothelial cells, and astrocytes (Pluchino
et al., 2005; Martino and Pluchino, 2006). It is therefore reason-
able to speculate that when inﬂammatory signals begin to fade,
transplanted cells are subsequently enabled to differentiate into
post-mitotic CNS cells.
We have shown that at 3 and 10 days post transplanta-
tion the majority of intravenously transplanted NPCs exhibit
an undifferentiated phenotype, lacking lineage-speciﬁc markers
such as microtubule-associated protein (MAP)-2, DCX, glial ﬁb-
rillary protein (GFAP), and the oligodendroglial transcription
factor (Olig)-2 (Bacigaluppi et al., 2009). Interestingly at 30 days
post transplantation, when inﬂammation was down regulated,
the number of transplanted NPCs expressing Olig2 and DCX
increased (albeit to only 4.4 and 0.8%, respectively, of the total),
whereas the majority of the transplanted cells still exhibited an
undifferentiated morphology in the brain tissue. Understanding
the mechanisms which foster graft differentiation and reduce the
quantity of NPCs restricted to an undifferentiated state (once
their therapeutic bystander effects have been fully exploited) is
of pivotal importance for future cell-replacement therapies in
stroke.
Valuable insights into the abovementioned may eventu-
ally come from the observation of the spontaneous dif-
ferentiation of endogenous neuroblasts after ischemic stroke
(Kernie and Parent, 2010). It has been reported that the major-
ity of neuroblasts after ischemia give rise to striatal medium
spiny neurons (Parent et al., 2002). This response can be mod-
ulated by the addition of growth factors (such as angiopoietin or
EGF),which increase the number of differentiated neurons and/or
drive the fating of speciﬁc neuronal subtypes (i.e., parvalbumin-
expressing interneurons; Teramoto et al., 2003; Liu et al., 2009).
The potential of pushing NPCs via growth factors toward spe-
ciﬁc neuronal subtypes has been exploited by a recent study on
induced human pluripotent stem (iPS) cells, which were fated
before local transplantation to obtain functional cortical neu-
rons in vivo (Tornero et al., 2013). Despite major methodological
advances associated with this approach, deﬁnitive proof regarding
the additional value of cell fating on behavioral recovery, when
compared to non-fated cellular grafts, is still lacking (Pluchino
and Peruzzotti-Jametti, 2013).
BYSTANDER EFFECTS OF TRANSPLANTED NPCs
Functional recovery of stroke-induced deﬁcits has similarly been
reported after intracerebral, intracerebroventricular, or intra-
venous NPC delivery (Bliss et al., 2007; Doeppner et al., 2012).
As already noted, the common ﬁnding to all routes of cell delivery
is the undifferentiated state in which the majority of transplanted
cells are found within the brain parenchyma (Jin et al., 2005). As
a matter of fact, the therapeutic potential of NPCs seems to be
initially independent of cell differentiation and rather relies on
the multiple bystander mechanisms exerted by adult NPCs, which
serve to boost restorative responses in the brain and modulate the
injured microenvironment (Martino et al., 2011).
We have shown that adult mouse NPCs reduced inﬂamma-
tory responses in the ischemic brain, thereby preventing delayed
neuronal degeneration and brain atrophy, even when trans-
planted intravenously as late as 3 days post MCAO (Bacigaluppi
et al., 2009). Iba-1+/MHC class II+ microglial activation was
reduced upon transplantation of adult NPCs, as was GFAP+
astroglial scar formation in the infarct rim (Bacigaluppi et al.,
2009). On the histochemical level, dopamine-2 receptor+, and
cAMP regulated phosphoprotein (DARPP)-32+ medium spiny
neurons were protected against delayed degeneration in the
striatum, which is particularly sensitive to intraluminal MCAO
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(Bacigaluppi et al., 2009). Diminished delayed neuronal degen-
eration was noticed not only inside the ischemic lesion but also
at distance to it, as the corpus callosum (CC) of mice receiv-
ing transplants of adult mouse NPCs was signiﬁcantly thicker
than those of control mice at 30 days post transplantation
(Bacigaluppi et al., 2009).
Further, transplanted NPCs were identiﬁed in close contact
with von Willebrand factor+ endothelial cells, CD45+ leuco-
cytes and F4/80+ macrophages (Bacigaluppi et al., 2009). On the
molecular level, pronounced down-regulation of messenger tran-
scripts of inﬂammatory signals (IFN-γ, TNF-α, IL-1β), regulators
of glial proliferation and reactivity (bFGF, vimentin) and neu-
ronal death and plasticity (caspase-3, growth associated protein-43,
versican) was observed in the brains of ischemic mice receiving
intravenous transplantation of adult mouse NPCs while a sin-
gle transcript was up-regulated by adult mouse NPCs, which was
the spiny neuron marker DARPP-32 (Bacigaluppi et al., 2009).
These data clearly suggest that NPCs modulate their microen-
vironment via inhibition rather than activation of transcriptional
processes.
Reduced delayed neuronal degeneration and CC atrophy were
also noticed with the grafting of human fetal NPCs into the ipsile-
sional cortex of rats at 7 days following distal MCAO (Andres
et al., 2011b). Dendritic branching, as evaluated by Golgi staining,
was enhanced by human fetal NPC transplantation, as was con-
tralesional corticospinal axonal sprouting (Andres et al., 2011b).
Accumulation of amyloid precursor protein was reduced by
human fetal NPC transplantation, pointing toward the restoration
of axonal transport processes (Andres et al., 2011b).
Although both systemic and intracerebral transplantation
improve neurological recovery, the restorative effects of each route
of transplantation exhibit important differences with regard to
the potential to inﬂuence injured tissue via bystander effects. The
local intracerebral grafting of adult mouse NPCs in the brain
parenchyma is associated with elevated brain concentrations of
BDNF, FGF, and VEGF in the subacute stroke phase, i.e., at
4 days after MCAO in mice (Doeppner et al., 2012). Notably,
such elevated growth factor levels could not be observed in the
ischemic brain after systemic intravenous NPC delivery, but were
still present for as late as 2 months after intracerebral transplanta-
tion of NPCs transduced with heat shock protein (Doeppner et al.,
2012).
CONCLUSION
Considering the lack of therapeutic options that promote brain
remodeling and neurological recovery after stroke, there is a clear
need to reevaluate therapeutic strategies and treatment modal-
ities within the stroke ﬁeld. Accumulating evidence suggests
that beyond the recanalization of blood vessels (by means of
thrombolytic therapies), it will not be possible to promote neuro-
logical recovery post-ischemia via the modulation of single targets
(Hermann and Chopp, 2012).
NPCs possess unique characteristics that differ drastically from
conventional therapies (namely pharmacological small molecule
compounds, recombinant growth factors and/or antibody-based
therapeutics). Transplanted stem cells can promote tissue regen-
eration by sensing diverse signals in the brain microenvironment,
migrating to speciﬁc sites of damage, integrating inputs and
executing complex response behaviors all aimed at the remodel-
ing/protection of injured ischemic tissue (Fischbach et al., 2013).
While the local delivery of NPCs is able to achieve high levels of
protective mediators (e.g., growth factors) in the ischemic brain
tissue, questions remain about the feasibility of such surgically
invasive procedures in the clinical setting. One might therefore
consider systemic NPC transplantation, which is minimally inva-
sive. In view that systemically administered NPCs do possess
potent anti-inﬂammatory effects, promote brain remodeling and
induce functional neurological recovery in rodents, this option
could be indeed of clinical value.
Future studies will have to clearly deﬁne the safety and efﬁcacy
of NPC transplantation after both systemic and local delivery. Such
knowledge will increase our understanding of cellular therapies
and in turn guide future translational strategies that are urgently
needed to promote brain remodeling and repair in stroke patients.
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